NO3042199T3 - - Google Patents
Info
- Publication number
- NO3042199T3 NO3042199T3 NO14789334A NO14789334A NO3042199T3 NO 3042199 T3 NO3042199 T3 NO 3042199T3 NO 14789334 A NO14789334 A NO 14789334A NO 14789334 A NO14789334 A NO 14789334A NO 3042199 T3 NO3042199 T3 NO 3042199T3
- Authority
- NO
- Norway
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1315748.2A GB201315748D0 (en) | 2013-09-04 | 2013-09-04 | Biological methods and materials for use therein |
| PCT/GB2014/052667 WO2015033136A1 (en) | 2013-09-04 | 2014-09-04 | Methods and kits for determining tuberculosis infection status |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO3042199T3 true NO3042199T3 (pl) | 2018-06-09 |
Family
ID=49397285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14789334A NO3042199T3 (pl) | 2013-09-04 | 2014-09-04 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10041944B2 (pl) |
| EP (1) | EP3042199B1 (pl) |
| CY (1) | CY1120220T1 (pl) |
| DK (1) | DK3042199T3 (pl) |
| ES (1) | ES2665605T3 (pl) |
| GB (1) | GB201315748D0 (pl) |
| HU (1) | HUE038739T2 (pl) |
| LT (1) | LT3042199T (pl) |
| NO (1) | NO3042199T3 (pl) |
| PL (1) | PL3042199T3 (pl) |
| PT (1) | PT3042199T (pl) |
| WO (1) | WO2015033136A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201315748D0 (en) | 2013-09-04 | 2013-10-16 | Imp Innovations Ltd | Biological methods and materials for use therein |
| CN107202882B (zh) * | 2016-03-17 | 2019-02-22 | 广东体必康生物科技有限公司 | Rv0440蛋白在诊断潜伏性/活动性肺结核中的用途 |
| EP3555630B1 (en) * | 2016-12-14 | 2023-05-31 | Becton, Dickinson and Company | Methods and compositions for obtaining a tuberculosis assessment in a subject |
| JOP20190187A1 (ar) | 2017-02-03 | 2019-08-01 | Novartis Ag | مترافقات عقار جسم مضاد لـ ccr7 |
| WO2018223151A1 (en) * | 2017-06-03 | 2018-12-06 | Flowmetric Life Sciences, Inc. | Flow cytometry system and methods for the diagnosis of infectious disease |
| CN111337681A (zh) * | 2020-03-20 | 2020-06-26 | 上海东方肝胆外科医院 | 评估肝细胞癌预后的标志物、试剂盒及方法 |
| WO2023170189A1 (en) * | 2022-03-09 | 2023-09-14 | Fundacio Privada Institut De Recerca De La Sida-Caixa | Boosted immune monitoring methods for assaying antigen-specific t cell responses |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7364869B2 (en) * | 2003-07-29 | 2008-04-29 | The J. David Gladstone Institutes | Method of detecting antigen-specific T lymphocytes |
| ITRM20040091A1 (it) | 2004-02-19 | 2004-05-19 | Istituto Naz Per Le Malattie | Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare. |
| EP1794187A4 (en) | 2004-08-19 | 2008-03-26 | Proteome Systems Intellectual | METHOD FOR THE DIAGNOSIS AND TREATMENT OF A M.TUBERCULOSIS INFECTION AND REAGENTS THEREFOR |
| JP5017269B2 (ja) | 2005-07-26 | 2012-09-05 | ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ | 結核状態に特有の抗体プロフィール |
| EP1996732A4 (en) | 2006-03-02 | 2010-03-31 | Uab Research Foundation | RECOGNITION AND TREATMENT AND DISCOVERY OF REMEDIES AGAINST MYCOBACTERIAL DISEASES |
| GB0605474D0 (en) | 2006-03-17 | 2006-04-26 | Isis Innovation | Clinical correlates |
| GB0708874D0 (en) | 2007-05-08 | 2007-06-13 | Univ The Of Birmingham | Assay for detecting mycrobacterial infection |
| EP2197908A2 (en) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| DE102007052518A1 (de) | 2007-10-29 | 2009-04-30 | Autoimmun Diagnostika Gmbh | Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen |
| US20110268744A1 (en) | 2008-05-26 | 2011-11-03 | Ian Garthwaite | Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor |
| MX2010014556A (es) | 2008-06-25 | 2011-07-28 | Baylor Res Inst | Firma transcripcional de sangre por infeccion de mycobacterium tuberculosis. |
| US20110129817A1 (en) | 2009-11-30 | 2011-06-02 | Baylor Research Institute | Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
| AP2011005772A0 (en) | 2008-12-15 | 2011-06-30 | Univ Cape Town | Method and device for diagnosing tuberculosis. |
| US20130018178A1 (en) | 2009-06-22 | 2013-01-17 | Px Therapeutics | Method for the purification of hbha |
| US8058022B2 (en) | 2009-07-27 | 2011-11-15 | Indian Institute Of Science | Diagnosis and monitoring of mycobacterium tuberculosis infection |
| US20110070599A1 (en) | 2009-09-18 | 2011-03-24 | Becton, Dickinson And Company | Method for Screening of Active Tuberculosis |
| WO2011044508A1 (en) | 2009-10-08 | 2011-04-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biomarkers for prognoses of pulmonary diseases |
| EP2548019A1 (en) | 2010-03-19 | 2013-01-23 | Red Flag Diagnostics GmbH | In vitro process for the quick determination of a patient's status relating to infection with mycobacterium tuberculosis |
| EP2655662A2 (en) | 2010-12-23 | 2013-10-30 | Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) | Methods for differentiating between disease states |
| CA2863236A1 (en) | 2012-01-31 | 2013-08-08 | Advanced Medical Research Institute Of Canada | Methods of determining cell mediated response |
| WO2014039044A1 (en) | 2012-09-06 | 2014-03-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing t memory stem cell populations |
| GB201315748D0 (en) * | 2013-09-04 | 2013-10-16 | Imp Innovations Ltd | Biological methods and materials for use therein |
-
2013
- 2013-09-04 GB GBGB1315748.2A patent/GB201315748D0/en not_active Ceased
-
2014
- 2014-09-04 NO NO14789334A patent/NO3042199T3/no unknown
- 2014-09-04 DK DK14789334.1T patent/DK3042199T3/en active
- 2014-09-04 ES ES14789334.1T patent/ES2665605T3/es active Active
- 2014-09-04 LT LTEP14789334.1T patent/LT3042199T/lt unknown
- 2014-09-04 US US14/916,632 patent/US10041944B2/en active Active
- 2014-09-04 WO PCT/GB2014/052667 patent/WO2015033136A1/en active Application Filing
- 2014-09-04 PT PT147893341T patent/PT3042199T/pt unknown
- 2014-09-04 PL PL14789334T patent/PL3042199T3/pl unknown
- 2014-09-04 HU HUE14789334A patent/HUE038739T2/hu unknown
- 2014-09-04 EP EP14789334.1A patent/EP3042199B1/en active Active
-
2018
- 2018-04-10 CY CY20181100387T patent/CY1120220T1/el unknown
- 2018-07-03 US US16/026,523 patent/US10883990B2/en active Active
-
2020
- 2020-11-30 US US17/106,294 patent/US11204352B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK3042199T3 (en) | 2018-04-23 |
| US20180313835A1 (en) | 2018-11-01 |
| EP3042199B1 (en) | 2018-01-10 |
| US20160195529A1 (en) | 2016-07-07 |
| PT3042199T (pt) | 2018-04-17 |
| US10883990B2 (en) | 2021-01-05 |
| LT3042199T (lt) | 2018-06-11 |
| ES2665605T3 (es) | 2018-04-26 |
| US11204352B2 (en) | 2021-12-21 |
| CY1120220T1 (el) | 2018-12-12 |
| HUE038739T2 (hu) | 2018-11-28 |
| PL3042199T3 (pl) | 2018-07-31 |
| US10041944B2 (en) | 2018-08-07 |
| WO2015033136A1 (en) | 2015-03-12 |
| GB201315748D0 (en) | 2013-10-16 |
| EP3042199A1 (en) | 2016-07-13 |
| US20210164979A1 (en) | 2021-06-03 |